Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

被引：121

作者：

Gill, H. S. ^{[1
]}

Soderholm, J. ^{[2
]}

Prausnitz, M. R. ^{[1
,3
]}

Sallberg, M. ^{[2
]}

机构：

[1] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA

[2] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Karolinska Inst, Stockholm, Sweden

[3] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA

来源：

GENE THERAPY | 2010年 / 17卷 / 06期

基金：

美国国家卫生研究院;

关键词：

cellular immune response; DNA-coated microneedle; DNA vaccine; hepatitis C virus; microfabricated needle; TRANSDERMAL DELIVERY; IN-VIVO; IMMUNIZATION; GENE; IMMUNOGENICITY; DEVICE;

D O I：

10.1038/gt.2010.22

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The skin is potentially an excellent organ for vaccine delivery because of accessibility and the presence of immune cells. However, no simple and inexpensive cutaneous vaccination method is available. Micron-scale needles coated with DNA were tested as a simple, inexpensive device for skin delivery. Vaccination with a plasmid encoding hepatitis C virus nonstructural 3/4A protein using microneedles effectively primed specific cytotoxic T lymphocytes (CTLs). Importantly, the minimally invasive microneedles were as efficient in priming CTLs as more complicated or invasive delivery techniques, such as gene gun and hypodermic needles. Thus, microneedles may offer a promising technology for DNA vaccination. Gene Therapy (2010) 17, 811-814; doi: 10.1038/gt.2010.22; published online 4 March 2010

引用

页码：811 / 814

页数：4

共 18 条

[1] In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells [J].

Ahlen, Gustaf ;

Soderholm, Jonas ;

Tjelle, Torunn ;

Kjeken, Rune ;

Frelin, Lars ;

Hoglund, Urban ;

Blomberg, Pontus ;

Fons, Michael ;

Mathiesen, Iacob ;

Sallberg, Matti .

JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4741-4753

[2] Cross-priming as a predominant mechanism for inducing CD8+ T cell responses in gene gun DNA immunization [J].

Cho, JH ;

Youn, JW ;

Sung, YC .

JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5549-5557

[3] Technical and regulatory hurdles for DNA vaccines [J].

Donnelly, J ;

Berry, K ;

Ulmer, JB .

INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2003, 33 (5-6) :457-467

[4] Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene [J].

Frelin, L ;

Ahlén, G ;

Alheim, M ;

Weiland, O ;

Barnfield, C ;

Liljeström, P ;

Sällberg, M .

GENE THERAPY, 2004, 11 (06) :522-533

[5] Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo [J].

Frelin, L ;

Alheim, M ;

Chen, A ;

Söderholm, J ;

Rozell, B ;

Barnfield, C ;

Liljeström, P ;

Sällberg, M .

GENE THERAPY, 2003, 10 (08) :686-699

[6] Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases [J].

Fuller, Deborah H. ;

Loudon, Peter ;

Schmaljohn, Connie .

METHODS, 2006, 40 (01) :86-97

[7] DNA vaccines for biodefence [J].

Garmory, HS ;

Perkins, SD ;

Phillpotts, RJ ;

Titball, RW .

ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (09) :1343-1361

[8] Effect of microneedle design on pain in human volunteers [J].

Gill, Harvinder S. ;

Denson, Donald D. ;

Burris, Brett A. ;

Prausnitz, Mark R. .

CLINICAL JOURNAL OF PAIN, 2008, 24 (07) :585-594

[9] Coating formulations for microneedles [J].

Gill, Harvinder S. ;

Prausnitz, Mark R. .

PHARMACEUTICAL RESEARCH, 2007, 24 (07) :1369-1380

[10] Coated microneedles for transdermal delivery [J].

Gill, Harvinder S. ;

Prausnitz, Mark R. .

JOURNAL OF CONTROLLED RELEASE, 2007, 117 (02) :227-237

← 1 2 →